0.70Open0.70Pre Close0 Volume1 Open Interest7.50Strike Price0.00Turnover91.96%IV10.76%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type-0.4201Delta0.2006Gamma10.89Leverage Ratio-0.0132Theta-0.0027Rho-4.57Eff Leverage0.0083Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet